Vedantham Srinivasan, Ananthakrishnan Radha, Schmidt Ann Marie, Ramasamy Ravichandran
Diabetes Research Program, Department of Medicine, New York University Langone Medical Center, New York, NY 10016, USA.
Cardiovasc Hematol Agents Med Chem. 2012 Sep;10(3):234-40. doi: 10.2174/187152512802651097.
Cardiovascular disease represents the major cause of morbidity and mortality in patients with diabetes mellitus. Studies by us and others have implicated increased flux via aldose reductase (AR) as a key player in mediating diabetic complications, including cardiovascular complications. Data suggest that increased flux via AR in diabetics perpetuates increased injury after myocardial infarction, accelerates atherosclerotic lesion formation, and promotes restenosis via multiple mechanisms. Most importantly, studies have shown that increased generation of reactive oxygen species due to flux via AR has been a common feature in animal models of diabetic cardiovascular disease. Taken together, these considerations place AR in the center of biochemical and molecular stresses that characterize the cardiovascular complications of diabetes. Stopping AR-dependent signaling may hold the key to interrupting cycles of cellular perturbation and tissue damage in diabetic cardiovascular complications.
心血管疾病是糖尿病患者发病和死亡的主要原因。我们和其他人的研究表明,醛糖还原酶(AR)通量增加是介导糖尿病并发症(包括心血管并发症)的关键因素。数据表明,糖尿病患者中AR通量增加会使心肌梗死后的损伤持续增加,加速动脉粥样硬化病变形成,并通过多种机制促进再狭窄。最重要的是,研究表明,AR通量导致的活性氧生成增加是糖尿病心血管疾病动物模型的一个共同特征。综上所述,这些因素使AR处于糖尿病心血管并发症所特有的生化和分子应激的中心位置。阻断AR依赖的信号传导可能是中断糖尿病心血管并发症中细胞扰动和组织损伤循环的关键。